Go to the list of all blogs
Allana's Avatar
published in Blogs
Jul 19, 2026
Teradyne (TER) Shares Drop -26% in 30 Days: Semiconductor Selloff Tests AI-Driven Growth

Teradyne (TER) Shares Drop -26% in 30 Days: Semiconductor Selloff Tests AI-Driven Growth

Key Takeaways

  • Teradyne shares dropped approximately 26% over the last 30 days, falling from $437.92 (June 18 close) to $322.36 (July 17 close), as a broader semiconductor equipment selloff intensified.
  • The decline was primarily driven by sector-wide pressure after TSMC's capital expenditure reset and ASML's cautious commentary sparked multiple compression across chip-equipment names.
  • Despite the sharp pullback, Teradyne's underlying business posted record Q1 2026 revenue of $1.28 billion — up 87% year-over-year — with roughly 70% now tied to AI-related demand.
  • Insider selling by the CEO and a director under pre-arranged 10b5-1 plans added to negative sentiment, though both transactions were scheduled months in advance and represented routine diversification.
  • Teradyne is scheduled to report Q2 2026 earnings on July 28, making that release a pivotal near-term catalyst for investor sentiment.

Teradyne (TER) Business Overview and Market Role

Teradyne, Inc. is a global leader in automated test equipment (ATE) and advanced robotics systems. The company designs, manufactures, and services testing solutions used by semiconductor manufacturers, electronics producers, and industrial automation customers worldwide. Its semiconductor test segment — which accounts for the largest share of revenue — validates chips across compute, memory, networking, and wireless applications before they ship to end markets. Teradyne also operates a growing industrial automation division that includes collaborative robots and autonomous mobile robots for manufacturing and warehouse environments. With a market capitalization of approximately $50 billion and trailing twelve-month revenue of $3.8 billion, the company occupies a critical position in the semiconductor supply chain. Investors closely track Teradyne (TER) as a bellwether for chip-industry capital spending and AI infrastructure demand.

TER Stock Performance: The Last 30 Days and the Broader Quarter

Over the last 30 days, Teradyne shares fell roughly 26%, sliding from a closing price of $437.92 on June 18 to $322.36 on July 17. The decline accelerated in early July, when the stock dropped from $483.84 on June 30 to $369.09 by July 2 — a two-session loss of nearly 24% — before extending its selloff through mid-July.

Zooming out to the full quarter, the stock's trajectory has been volatile. From mid-April, when shares traded near $380, Teradyne rallied more than 27% to an all-time intraday high of $487.91 on June 30. That peak proved short-lived. The subsequent correction erased all quarterly gains and pushed the stock into negative territory, leaving it down roughly 15% from its mid-April level by July 17. The 52-week range now spans from $89.18 to $487.91, underscoring both the magnitude of the recent run-up and the severity of the pullback.

Drivers Behind the Recent 30-Day Decline

The primary catalyst for the selloff was a sector-wide reassessment triggered by Taiwan Semiconductor Manufacturing Company (TSM). Despite reporting record profits and raising its full-year 2026 revenue growth forecast to slightly above 40%, TSMC simultaneously revised its capital expenditure guidance upward to $60–$64 billion — well above the prior $56 billion ceiling — and warned that overseas expansion and 2-nanometer ramp costs would compress gross margins in the second half of the year. The read-through for semiconductor equipment suppliers like Teradyne was immediate: scaling AI manufacturing capacity will be exceptionally expensive, and the cost burden may weigh on profitability across the supply chain. The selloff was compounded a day earlier when ASML (ASML) also triggered caution in the equipment space.

Adding to the negative sentiment, two insider stock sales were disclosed in mid-July. CEO Gregory Stephen Smith sold 4,000 shares at $356.31 on July 15 under a Rule 10b5-1 plan adopted in February 2026, and director Marilyn Matz sold 1,200 shares the same day under a separate pre-arranged plan. While both transactions represented routine portfolio diversification — Smith still holds over 116,000 shares — the optics of insider selling near the stock's peak drew attention. Separately, the company's Q2 2026 earnings report, scheduled for July 28, loomed as an uncertainty factor, with analysts expecting EPS of $2.04, up sharply from $0.57 a year earlier. From what I see, this combination of macro pressure and routine insider activity created a perfect storm for the pullback.

Quarterly Performance: Strong Fundamentals Meet Market Uncertainty

The quarter was defined by two opposing forces: exceptional fundamental strength and intensifying macro uncertainty. Teradyne's Q1 2026 results, released on April 29, showed record revenue of $1.28 billion — an 87% year-over-year surge — and non-GAAP EPS of $2.56, well above the $2.11 consensus. AI-related demand accounted for roughly 70% of revenue, and management highlighted its "wafer to AI data center strategy" along with the company's first merchant GPU test orders. Despite the beat, shares fell approximately 19% the following session, as broader AI-spending jitters overshadowed the strong print.

The stock recovered and rallied to new highs through late June, supported by analyst upgrades. Cantor Fitzgerald raised its price target to $550, Goldman Sachs lifted its target to $465, and JPMorgan upgraded the stock to Overweight. However, the July rotation out of high-multiple semiconductor names erased those gains. The quarter thus illustrates a market grappling with the tension between undeniable AI-driven revenue growth and the risk that capital spending cycles may not sustain current valuations. I’m watching this closely as earnings approach.

TER Stock Outlook: Key Factors to Monitor

The most immediate catalyst is Teradyne's Q2 2026 earnings report on July 28, where investors will scrutinize revenue growth, AI-related order trends, and forward guidance. Analysts expect EPS of $2.04, and any deviation could significantly move the stock. Beyond earnings, key factors include the pace of capital expenditure among major semiconductor manufacturers — particularly TSMC, Intel (INTC), and Samsung — as well as hyperscaler AI infrastructure budgets. Macroeconomic variables such as inflation data, Federal Reserve policy, and geopolitical tensions will also influence sentiment for high-beta tech stocks. The concentration of Teradyne's revenue in AI-exposed semiconductor test equipment remains both its greatest strength and its most significant vulnerability. The consensus analyst price target of approximately $390 suggests Wall Street sees recovery potential, but the path forward hinges on sustained AI demand and disciplined execution.

Using AI Tools for Pattern Recognition in Volatile Markets

In volatile market environments like the one currently facing semiconductor stocks, traders often turn to data-driven tools for identifying patterns and managing risk. Tickeron's Trending AI Robots page offers a curated selection of AI-powered trading bots drawn from a universe of hundreds of bots trading thousands of tickers. Only the top-performing and most relevant strategies make it into this section, with bots spanning different timeframes, methodologies, and performance metrics. Whether focused on momentum, swing trading, or mean reversion, each bot is designed to execute trades based on statistical models and historical pattern recognition rather than emotion. Investors looking to complement their own analysis can explore the page to see which AI-driven strategies are currently generating the strongest signals. I also checked sector comparisons recently using Tickeron’s AI Screener to see how Teradyne stacks up against peers in the equipment space.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: TER

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.


TER in upward trend: 10-day moving average crossed above 50-day moving average on September 28, 2026

The 10-day moving average for TER crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 11 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 85%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on TER as a result. In 61 of 88 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 69%.

The Moving Average Convergence Divergence (MACD) for TER just turned positive on September 18, 2026. Looking at past instances where TER's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.

TER moved above its 50-day moving average on September 18, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +12.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where TER advanced for three days, in 254 of 315 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

The Aroon Indicator entered an Uptrend today. In 266 of 317 cases where TER Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 84%.

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 10 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TER declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

TER broke above its upper Bollinger Band on October 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 8 (best 1 - 100 worst), indicating outstanding price growth. TER’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 21 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: TER's P/B Ratio (18.248) is slightly higher than the industry average of (8.078). P/E Ratio (55.124) is within average values for comparable stocks, (161.623). Projected Growth (PEG Ratio) (0.734) is also within normal values, averaging (0.801). Dividend Yield (0.001) settles around the average of (0.002) among similar stocks. P/S Ratio (12.077) is also within normal values, averaging (27.897).

Notable companies

The most notable companies in this group are Lam Research Corp (NASDAQ:LRCX), Applied Materials (NASDAQ:AMAT), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 63.66B. The market cap for tickers in the group ranges from 326.86K to 671.68B. ASML holds the highest valuation in this group at 671.68B. The lowest valued company is AVSR at 326.86K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 7%. For the same Industry, the average monthly price growth was 13%, and the average quarterly price growth was 19%. INTT experienced the highest price growth at 28%, while SMTK experienced the biggest fall at -30%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 15%. For the same stocks of the Industry, the average monthly volume growth was -12% and the average quarterly volume growth was -63%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 34
Price Growth Rating: 42
SMR Rating: 71
Profit Risk Rating: 59
Seasonality Score: 27 (-100 ... +100)
View a ticker or compare two or three
TER
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an electronic test systems manufacturer

Industry ElectronicProductionEquipment

Industry
Electronic Production Equipment
Address
600 Riverpark Drive
Phone
+1 978 370-2700
Employees
6600
Web
https://www.teradyne.com
Interact to see
Advertisement
UBXG stock surged +79% over the last 30 days, driven by heightened trading volume and positive market sentiment amid broader technology sector trends. Over the past quarter, the stock rose +61%, reflecting recovery from earlier lows near its 52-week bottom.
CVGI stock surged approximately +89% over the last 30 days, driven by strong Q4 2025 earnings beat on revenue and positive 2026 guidance. Over the past quarter, shares rose about +126%, reflecting improved profitability, debt reduction, and a key partnership announcement.
SAFX stock surged +104% over the past 30 days, driven by positive updates on a $10 million capital raise and merger progress. Over the past quarter, the stock rose +44%, reflecting recovery from lows amid renewable energy sector interest and strategic developments.
LONA stock surged +80% over the past 30 days, driven by positive analyst upgrades, executive appointments, and full-year financial updates highlighting pipeline progress. Over the past quarter, shares rose +48%, reflecting improved investor sentiment in biotech amid clinical advancements.
Lifetime Brands (LCUT) stock surged +77% over the last 30 days, driven by a strong Q4 earnings beat and a Zacks Rank #1 (Strong Buy) upgrade that reflects an improved earnings outlook. Over the past quarter, shares rose +48%, supported by profitability gains despite softer sales, with adjusted EBITDA reaching $50.8 million for full-year 2025.
CURV stock surged approximately +73% over the last 30 days, driven primarily by a positive reaction to Q4 and fiscal 2025 earnings that beat expectations on EPS and revenue. Over the past quarter, the stock is up around +55%, reflecting recovery from lows near $1 amid ongoing store optimization and sub-brand launches
Blaize Holdings, Inc. (BZAI) focuses on artificial intelligence (AI)-enabled edge computing solutions, offering programmable AI processors and platforms for verticals such as smart cities, defense, retail, and enterprise markets. The company's core revolves around hardware like the Graph Streaming Processor (GSP) AI accelerator, compute cards, and software tools including Blaize AI Studio—a no-code/low-code environment for deploying AI models without source code expertise. Based in El Dorado Hills, California, and founded in 2010, it went public through a merger in early 2025.
Comstock Holding Companies, Inc. (CHCI) operates as an asset manager, developer, and operator of mixed-use and transit-oriented properties, mainly in the greater Washington, D.C. metropolitan area. The company targets high-growth urban and suburban markets, overseeing a portfolio that spans residential, commercial, hospitality, and parking assets near key metro stations. Its asset-light, fee-based model delivers recurring revenue through property management, leasing, development services, and asset recapitalization for institutional investors, family offices, and governments.
ARM stock surged +26% over the past 30 days, driven by announcements of in-house chip production and strong analyst upgrades amid AI enthusiasm. Over the past quarter, the stock climbed +38%, reflecting robust Q3 earnings beat with 26% revenue growth and data center royalty doubling.
Sable Offshore Corp. (SOC) is an independent oil and gas company focused on offshore operations in federal waters off California. The company owns and operates three platforms in the Santa Ynez Unit (SYU), spanning 16 federal leases across approximately 76,000 acres, along with subsea pipelines for crude oil, natural gas, and produced water transport to onshore facilities. Its core business model centers on restarting and developing prolific fields like the SYU, which had been idle due to regulatory and legal hurdles following a 2015 pipeline spill.
From what I see, Cheniere Energy Partners (CQP) holds a commanding position through its ownership and operation of the Sabine Pass LNG terminal in Louisiana, the largest LNG production facility in the U.S. with approximately 30 million tonnes per annum (mtpa) capacity across six trains, alongside the connected Creole Trail Pipeline. This setup makes CQP a leader in U.S. LNG exports, which have accounted for about 11% of global supply in recent years. The company's ~80% contracted production through long-term sale and purchase agreements (SPAs) provides revenue stability, with weighted average remaining lives of around 13 years.
In my view, Regeneron Pharmaceuticals holds a strong leadership position in biotechnology, thanks to its proprietary VelociSuite technologies, including VelocImmune for fully human antibody discovery. This enables a robust pipeline across immunology, oncology, ophthalmology, and rare diseases. The company's integrated model—from discovery to commercialization—drives high R&D productivity, with approximately 45 clinical programs and key partnerships like Sanofi for Dupixent and Bayer for EYLEA.
As I review argenx SE's place in the market, its strong footing in immunology stands out. This commercial-stage biopharmaceutical company focuses on differentiated antibody therapies for severe autoimmune diseases. The flagship product, VYVGART (efgartigimod), a first-in-class neonatal Fc receptor (FcRn) inhibitor, has secured leadership in generalized myasthenia gravis (gMG) and chronic inflammatory demyelinating polyneuropathy (CIDP), with approvals across the U.S., Europe, and Japan. The Immunology Innovation Program (IIP) fuels a robust pipeline, featuring next-generation FcRn candidates like ARGX-213 and ARGX-124, alongside first-in-class assets such as empasiprubart (C2 inhibitor, ARGX-117) and adimanebart (MuSK agonist).
I've long admired Alnylam Pharmaceuticals as the pioneer in RNA interference (RNAi) therapeutics, a gene-silencing technology that has delivered six approved products, including AMVUTTRA (vutrisiran), ONPATTRO (patisiran), GIVLAARI (givosiran), and OXLUMO (lumasiran). The company's proprietary platform, enhanced by GalNAc conjugation for liver targeting and emerging extra-hepatic delivery innovations, creates a solid competitive moat in precision genetic medicines.
As I review BeOne Medicines AG's position in the oncology space, what stands out is its role as a global leader with a diversified portfolio that includes both commercial-stage therapies and a deep pipeline targeting hematologic and solid tumors. The flagship product, BRUKINSA (zanubrutinib), a Bruton's Tyrosine Kinase (BTK) inhibitor, has secured approvals in over 75 markets, solidifying its dominance in chronic lymphocytic leukemia (CLL) and other blood cancers. This is complemented by TEVIMBRA (tislelizumab), an anti-PD-1 antibody approved in more than 50 markets for various indications, which broadens its reach in immunotherapy.
Rio Tinto holds a premier position as one of the world's largest mining companies, anchored by low-cost, Tier 1 assets. Its Pilbara iron ore operations in Australia deliver industry-leading margins, thanks to integrated rail and port infrastructure that gives it a structural cost advantage over higher-cost producers. In copper, the company has significant stakes in Escondida, the world's largest copper mine, and full ownership of Oyu Tolgoi in Mongolia, setting it up well to benefit from tightening supply as demand surges for electrification and renewables.
I've always been impressed by how Visa (V) commands the global payments landscape. As an open-loop network, it connects issuers, acquirers, merchants, and consumers without issuing cards or extending credit itself. The VisaNet platform processes over 65,000 transactions per second across more than 200 countries, supporting a ~52% share of the global credit card market and ~60% of debit. This scale generates powerful network effects, where greater adoption benefits everyone involved and creates formidable barriers to entry.
Following the Kenvue consumer health spin-off, Johnson & Johnson has transformed into a focused healthcare leader, emphasizing Innovative Medicine (pharmaceuticals) and MedTech (devices). In my view, this repositioning sharpens the company's edge in high-margin areas such as oncology, immunology, neuroscience, cardiovascular, surgery, and vision, where its diversified portfolio and R&D efficiency provide clear competitive advantages.
I've long appreciated ASML Holding N.V.'s dominant position in the semiconductor lithography market. The company commands over 90% share in advanced deep ultraviolet (DUV) immersion systems and 100% in EUV lithography—the critical technology for chips below 7nm nodes used in AI, high-performance computing, and memory. This near-monopoly comes from decades of R&D investment, exclusive partnerships like Zeiss for optics, and a vast installed base that generates steady service revenue. From what I see, competitors such as Nikon and Canon remain far behind in EUV, sticking to mature nodes.
I've been watching Micron Technology (MU) closely through its recent volatility, which mirrors the semiconductor sector's heightened sensitivity to AI demand and supply constraints. The stock saw a sharp post-earnings sell-off tied to elevated capital expenditure plans, yet it has rebounded with surging DRAM prices—up 90-95%—and memory suppliers booked out for years. From what I see, broader tech optimism, including key partnerships and persistent supply tightness, is driving upward momentum. This positions MU as a pivotal player in high-bandwidth memory (HBM) for data centers. Trading near recent highs around $368, the shares highlight investor focus on Micron's critical role in the AI infrastructure expansion under these constrained industry conditions.